-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Regen BioPharma Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2024.
- Regen BioPharma Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$265K, a 18.5% increase year-over-year.
- Regen BioPharma Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$867K.
- Regen BioPharma Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$867K, a 175% decline from 2023.
- Regen BioPharma Inc annual Net Income (Loss) Attributable to Parent for 2023 was $1.16M, a 52.7% decline from 2022.
- Regen BioPharma Inc annual Net Income (Loss) Attributable to Parent for 2022 was $2.44M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)